Race Oncology (RAC.AX) Earnings Analysis
Race Oncology (RAC.AX) next reports earnings on 2026-09-01. Trailing P/E -37.89.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RAC.AX next report earnings?
| Next earnings date | 2026-09-01 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
RAC.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | -0.0233 AUD | n/a | n/a | n/a |
| 2025-02-26 | 0.0026 AUD | n/a | n/a | n/a |
| 2024-10-21 | -0.04933 AUD | n/a | n/a | n/a |
RAC.AX valuation and analyst view
| Trailing P/E | -37.89 |
|---|---|
| Trailing EPS | -0.05337 AUD |
| Price / book | 15.30 |
| Dividend yield | 0.00% |
| Market cap | 0.40B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Race Oncology (RAC.AX)'s next earnings date?
Race Oncology is next scheduled to report on 2026-09-01.
Did RAC.AX beat earnings last quarter?
Consensus estimate data was not available for RAC.AX's 2026-02-26 report.
What is RAC.AX's current P/E ratio and EPS?
RAC.AX trades at a trailing P/E of -37.89 on trailing EPS of -0.05336763003078081 AUD.
What do analysts rate RAC.AX?
RAC.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.